Form D · Manufacturing
PharmAdva, LLC
Rochester, NY · CIK 0002067748
Offering snapshot reported Jan 23, 2026 · SEC filing
- Reported sold
- $550K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jan 21, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 23, 2026 | Initial | $550,000 | No comparison | 2 | SEC filing |
| May 13, 2025 | Initial | $986,748 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-570991
Source: Form D, filed Jan 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Allen | Director |
| Mark Ambruster | Director |
| Michael Berg | Director, Executive |
| Jim Brush | Director |
| Joel Reiser | Director |
| Jonathan Sacks | Director |
| Pamela Schwitzer | Director |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
1565 Jefferson Road Suite 200
Rochester, NY, 14623
Rochester, NY, 14623